Garg S, Ochetto A, Hu J, Wang J
Viruses. 2025; 17(1).
PMID: 39861834
PMC: 11768703.
DOI: 10.3390/v17010048.
Norizwan J, Tan W
Curr Res Microb Sci. 2024; 8:100317.
PMID: 39717209
PMC: 11665419.
DOI: 10.1016/j.crmicr.2024.100317.
Travassos R, Martins S, Fernandes A, Correia J, Melo R
Int J Mol Sci. 2024; 25(12).
PMID: 38928403
PMC: 11204272.
DOI: 10.3390/ijms25126699.
Petrov G, Galkina D, Koldina A, Grebennikova T, Eliseeva O, Chernoryzh Y
Pharmaceutics. 2024; 16(2).
PMID: 38399241
PMC: 10891502.
DOI: 10.3390/pharmaceutics16020180.
Dang M, Wu L, Zhang S, Zhu J, Hu Y, Yang C
ACS Synth Biol. 2023; 12(12):3704-3715.
PMID: 37946498
PMC: 10729756.
DOI: 10.1021/acssynbio.3c00503.
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Ruzzi F, Semprini M, Scalambra L, Palladini A, Angelicola S, Cappello C
Int J Mol Sci. 2023; 24(16).
PMID: 37629147
PMC: 10454695.
DOI: 10.3390/ijms241612963.
Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines.
Filipic B, Pantelic I, Nikolic I, Majhen D, Stojic-Vukanic Z, Savic S
Vaccines (Basel). 2023; 11(7).
PMID: 37514991
PMC: 10385383.
DOI: 10.3390/vaccines11071172.
Micro and nanotechnologies: The little formulations that could.
Stiepel R, Duggan E, Batty C, Ainslie K
Bioeng Transl Med. 2023; 8(2):e10421.
PMID: 36925714
PMC: 10013823.
DOI: 10.1002/btm2.10421.
Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery.
Srivastava V, Nand K, Ahmad A, Kumar R
Vaccines (Basel). 2023; 11(2).
PMID: 36851356
PMC: 9965603.
DOI: 10.3390/vaccines11020479.
Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo.
Obozina A, Komedchikova E, Kolesnikova O, Iureva A, Kovalenko V, Zavalko F
Pharmaceutics. 2023; 15(1).
PMID: 36678860
PMC: 9861179.
DOI: 10.3390/pharmaceutics15010231.
Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2.
Mohamed N, Abou-Saleh H, Mohamed H, Al-Ghouti M, Crovella S, Zupin L
Viruses. 2022; 14(7).
PMID: 35891532
PMC: 9318803.
DOI: 10.3390/v14071553.
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines.
Tornesello A, Tagliamonte M, Buonaguro F, Tornesello M, Buonaguro L
Vaccines (Basel). 2022; 10(2).
PMID: 35214685
PMC: 8879290.
DOI: 10.3390/vaccines10020227.
Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines.
Balkrishna A, Arya V, Rohela A, Kumar A, Verma R, Kumar D
Vaccines (Basel). 2021; 9(10).
PMID: 34696237
PMC: 8537718.
DOI: 10.3390/vaccines9101129.
Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.
Moradi Vahdat M, Hemmati F, Ghorbani A, Rutkowska D, Afsharifar A, Eskandari M
Biotechnol Rep (Amst). 2021; 29:e00605.
PMID: 33732633
PMC: 7937989.
DOI: 10.1016/j.btre.2021.e00605.
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.
Nooraei S, Bahrulolum H, Hoseini Z, Katalani C, Hajizade A, Easton A
J Nanobiotechnology. 2021; 19(1):59.
PMID: 33632278
PMC: 7905985.
DOI: 10.1186/s12951-021-00806-7.
Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine.
Laugi H
Euroasian J Hepatogastroenterol. 2021; 10(2):105-108.
PMID: 33511075
PMC: 7801885.
DOI: 10.5005/jp-journals-10018-1326.
Nobel Prize for the Discovery of Hepatitis B and C: A Brief History in Time.
Al-Mahtab M, Roy P, Khan M, Akbar S
Euroasian J Hepatogastroenterol. 2021; 10(2):98-100.
PMID: 33511072
PMC: 7801893.
DOI: 10.5005/jp-journals-10018-1328.
Virus-like Particle (VLP) Mediated Antigen Delivery as a Sensitization Tool of Experimental Allergy Mouse Models.
Kim J, Oh J, Kang C, Choi Y
Immune Netw. 2020; 20(4):e35.
PMID: 32895622
PMC: 7458801.
DOI: 10.4110/in.2020.20.e35.
Intracellular Trafficking of HBV Particles.
Jiang B, Hildt E
Cells. 2020; 9(9).
PMID: 32887393
PMC: 7563130.
DOI: 10.3390/cells9092023.
Hepatitis C Virus: 30 Years after Its Discovery.
Houghton M
Cold Spring Harb Perspect Med. 2019; 9(12).
PMID: 31501269
PMC: 6886456.
DOI: 10.1101/cshperspect.a037069.
